Lineage Cell Therapeutics OverviewLineage Cell Therapeutics Net Income
Profitability analysis for LCTX.
Quarterly Net Income
-$4.81M
↓ 16.26% YoY
As of Mar 2026
Annual Net Income (TTM)
-$64.21M
↓ 296.19% YoY
Trailing 12 months ending Mar 2026
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...